ARTICLE | Company News
Isis deal
May 30, 1995 7:00 AM UTC
Ciba-Geigy Ltd. has accepted ISIS 5132 (CGP 69846 A), an antisense cancer drug, as an early development compound under the companies' cooperative research agreement. The Carlsbad, Calif., company's ol...